Article: MALAYSIAN HEALTH MINISTRY SUSPENDS RAPTIVA.

KUALA LUMPUR, March 4 Asia Pulse - The Malaysian Health Ministry has suspended the product Raptiva immediately because its risks outweigh its benefits and it can cause death.

The ministry's Pharmaceutical Services Senior Director, Eisah A. Rahman, said serious side effects had been reported between September last year and January this year, including three confirmed cases of "progressive multifocal leukoencephalopathy", a rare brain infection, in patients who had taken Raptiva for more than three years and two of the three cases resulted in the patient's death.

She ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!